Cargando…
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
Poxvirus vectors represent versatile modalities for engineering novel vaccines and cancer immunotherapies. In addition to their oncolytic capacity and immunogenic influence, they can be readily engineered to express multiple large transgenes. However, the integration of multiple payloads into poxvir...
Autores principales: | Whelan, Jack T., Singaravelu, Ragunath, Wang, Fuan, Pelin, Adrian, Tamming, Levi A., Pugliese, Giuseppe, Martin, Nikolas T., Crupi, Mathieu J. F., Petryk, Julia, Austin, Bradley, He, Xiaohong, Marius, Ricardo, Duong, Jessie, Jones, Carter, Fekete, Emily E. F., Alluqmani, Nouf, Chen, Andrew, Boulton, Stephen, Huh, Michael S., Tang, Matt Y., Taha, Zaid, Scut, Elena, Diallo, Jean-Simon, Azad, Taha, Lichty, Brian D., Ilkow, Carolina S., Bell, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880309/ https://www.ncbi.nlm.nih.gov/pubmed/36713447 http://dx.doi.org/10.3389/fimmu.2022.1050250 |
Ejemplares similares
-
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
por: Boulton, Stephen, et al.
Publicado: (2023) -
SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition
por: Azad, Taha, et al.
Publicado: (2021) -
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
por: Boulton, Stephen, et al.
Publicado: (2022) -
Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
por: Azad, Taha, et al.
Publicado: (2020) -
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
por: Azad, Taha, et al.
Publicado: (2021)